ANIXA BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR CAR-T TECHNOLOGY, FURTHER STRENGTHENING ITS ROBUST INTELLECTUAL PROPERTY PORTFOLIO

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent application covering its chimeric antigen receptor-T cell (CAR-T) technology.

Information taken from PR NewsWire :https://www.prnewswire.com/news-releases/anixa-biosciences-receives-notice-of-allowance-from-us-patent-and-trademark-office-for-car-t-technology-further-strengthening-its-robust-intellectual-property-portfolio-302427188.html

#intellectualproperty #patent #trademark #laws